These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37355392)

  • 101. [Patterns of recurrence after neoadjuvant chemoradiotherapy compared with surgery alone in esophageal cancer].
    Yang YS; Chen LQ
    Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):651-654. PubMed ID: 34192856
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Oncological recurrence following pathological complete response after neoadjuvant treatment in patients with esophageal cancer - a retrospective cohort study.
    Hipp J; Kuvendjiska J; Hillebrecht HC; Herrmann S; Timme-Bronsert S; Fichtner-Feigl S; Hoeppner J; Diener MK
    Langenbecks Arch Surg; 2023 Sep; 408(1):363. PubMed ID: 37721586
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Clinical Outcomes of Treatment for Esophageal Cancer Recurrence after Surgery].
    Takebayashi K; Kaida S; Otake R; Matsunaga T; Miyake T; Kojima M; Tani S; Maehira H; Mori H; Nishina Y; Zen Y; Takenaka Y; Naito S; Ishikawa H; Tani M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1944-1946. PubMed ID: 38303259
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Prognostication for recurrence patterns after curative resection for pancreatic ductal adenocarcinoma.
    Ang A; Michaelides A; Chelala C; Ullah D; Kocher HM;
    Ann Hepatobiliary Pancreat Surg; 2024 May; 28(2):248-261. PubMed ID: 38556877
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation.
    Triantafyllou T; Wijnhoven B
    Ann Gastroenterol Surg; 2020 Jul; 4(4):352-359. PubMed ID: 32724878
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer.
    van der Zijden CJ; van der Sluis PC; Mostert B; Nuyttens JJME; Spaander MCW; Toxopeus ELA; Valkema R; Beerepoot LV; van Halteren HK; Lagarde SM; Wijnhoven BPL
    Eur J Surg Oncol; 2024 Mar; 50(3):107968. PubMed ID: 38241878
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Patient choice of surgery or surveillance following a clinical complete response to neoadjuvant chemoradiotherapy for oesophageal carcinoma.
    Walsh TN; Kharytaniuk N; Furlong H; Sorensen J; O'Neill BDP; Breathnach OS; Grogan L
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 37933675
    [No Abstract]   [Full Text] [Related]  

  • 108. Diagnostic workup for esophageal cancer patients can be improved with checklists and clearer protocols; a comparative study between two tertiary centers in Europe.
    van Doesburg JR; Luttikhold J; Lindblad M; van Berge Henegouwen MI; Eshuis WJ; Derks S; Geijsen ED; Pouw RE; Gisbertz SS; Nilsson M; Daams F
    Eur J Surg Oncol; 2024 Feb; 50(2):107318. PubMed ID: 38145609
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Endoscopic ultrasound for structured surveillance after curative treatment of esophageal cancer.
    Bohle W; Nowack L; Schaudt A; Koeninger J; Zoller WG; Albert JG
    Z Gastroenterol; 2024 May; 62(5):737-746. PubMed ID: 38198802
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Impact of bulky loco-regional lymphadenopathy in esophageal adenocarcinoma on survival: a retrospective single center analysis.
    Tankel J; Nevo Y; Al Shehhi R; Sakalla R; Dehghani M; Spicer J; Najmeh S; Mueller C; Ferri L; Cools-Lartigue J
    Dis Esophagus; 2024 Jun; ():. PubMed ID: 38862393
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Multimodality management of esophageal cancer.
    Purwar P; Bambarkar S; Jiwnani S; Karimundackal G; Laskar SG; Pramesh CS
    Indian J Surg; 2014 Dec; 76(6):494-503. PubMed ID: 25614726
    [TBL] [Abstract][Full Text] [Related]  

  • 112. An optimized postsurgery follow-up strategy for patients with esophageal cancer: a cohort study.
    Mai Z; Xie J; Leng C; Xie X; Wen J; Yang H; Liu Q; Fu J
    Int J Surg; 2024 Jan; 110(1):332-341. PubMed ID: 37916933
    [TBL] [Abstract][Full Text] [Related]  

  • 113. ASO Visual Abstract: Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Retrospective Study.
    Li J; Wang Q
    Ann Surg Oncol; 2024 Jul; ():. PubMed ID: 38958805
    [No Abstract]   [Full Text] [Related]  

  • 114. ASO Author Reflections: Fathoming the Dilemma of the Optimal Time to Surgery for Patients with Resectable Esophageal Cancer After Neoadjuvant Chemoradiotherapy.
    Li J; Wang Q
    Ann Surg Oncol; 2024 Jun; 31(6):3852-3853. PubMed ID: 38270832
    [No Abstract]   [Full Text] [Related]  

  • 115. Correction to: 176. NON-REGIONAL LYMPHADENOPATHY IN PATIENTS WITH ESOPHAGEAL CANCER TREATED WITH CURATIVE INTENT: A PROPENSITY MATCHED ANALYSIS OF PATHOLOGICAL AND SURVIVAL OUTCOMES.
    Dis Esophagus; 2024 Jan; 37(2):. PubMed ID: 37987088
    [No Abstract]   [Full Text] [Related]  

  • 116. De-escalation of loco-regional treatments: Time to find a balance.
    Gentilini OD; Cardoso MJ; Senkus E; Poortmans P
    Breast; 2024 Feb; 73():103673. PubMed ID: 38295751
    [No Abstract]   [Full Text] [Related]  

  • 117. ASO Visual Abstract: Survival Outcomes for Patients with Esophageal Cancer and Post-Chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?
    Yang TY; Yeh CJ; Chiu CH; Chao YK
    Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38900351
    [No Abstract]   [Full Text] [Related]  

  • 118. The Expression of TP63 as a Biomarker of Early Recurrence in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy.
    Lin CH; Cheng PL; Chuang CY; Kang YT; Lee LW; Hsiao TH; Hsu CP
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791062
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinoma.
    Henckens SPG; Liu D; Gisbertz SS; Kalff MC; Anderegg MCJ; Crull D; Daams F; van Dalsen AD; Dekker JWT; van Det MJ; van Duijvendijk P; Eshuis WJ; Groenendijk RPR; Haveman JW; van Hillegersberg R; Luyer MDP; Olthof PB; Pierie JEN; Plat VD; Rosman C; Ruurda JP; van Sandick JW; Sosef MN; Voeten DM; Vijgen GHEJ; Bijlsma MF; Meijer SL; Hulshof MCCM; Oyarce C; Lagarde SM; van Laarhoven HWM; van Berge Henegouwen MI;
    Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38387083
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.